What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis, Literature Review).

August 18, 2025Medical SciencesOpen Access

Current and Emerging Therapeutic Strategies for Limited- and Extensive-Stage Small-Cell Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

Current standards improve outcomes for small-cell lung cancer, highlighting the role of immunotherapy and chemoradiotherapy.

Immunotherapy significantly advances the treatment landscape, particularly for extensive-stage small-cell lung cancer.
Limited-stage small-cell lung cancer primarily utilizes concurrent chemoradiotherapy alongside emerging immunotherapy strategies.
Integration of immune checkpoint inhibitors with chemotherapy sets a new standard of care for extensive-stage small-cell lung cancer.
Future developments focus on predictive biomarkers and novel therapies to enhance patient outcomes in this aggressive malignancy.

Shalata et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark